down arrow

Jeevan Scienti.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE237B01018
  • NSEID:
  • BSEID: 538837
INR
41.89
0.15 (0.36%)
BSENSE

Apr 11, 12:46 PM

BSE+NSE Vol: 3.25 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

41.6941.90

52 Week

37.9967.80
Valuation
Technical
Day's Volume

CASH

3.25 k (31.60%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

37.84%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Bearish range

  • The technical trend has deteriorated from Mildly Bearish on 24-Feb-25 and has generated -12.27% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 66 Cr (Micro Cap)

stock-summary
P/E

66.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

0.24%

stock-summary
Price to Book

1.32

Revenue and Profits (1 Year):
Net Sales:
13 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-23.15%
0%
-23.15%
1 Year
-19.29%
0%
-19.29%
2 Years
-19.98%
0%
-19.98%
3 Years
-72.4%
1.58%
-70.82%
4 Years
-39.25%
1.79%
-37.46%
5 Years
136.0%
8.37%
144.37%

Latest dividend: 1.2 per share ex-dividend date: Sep-21-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.69%
EBIT Growth (5y)
21.63%
EBIT to Interest (avg)
3.60
Debt to EBITDA (avg)
5.34
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.79
Tax Ratio
68.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.72%
ROE (avg)
13.07%
Valuation key factors
Factor
Value
P/E Ratio
66
Industry P/E
33
Price to Book Value
1.32
EV to EBIT
29.99
EV to EBITDA
9.09
EV to Capital Employed
1.25
EV to Sales
1.67
PEG Ratio
0.53
Dividend Yield
NA
ROCE (Latest)
2.63%
ROE (Latest)
0.24%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Krishna Kishore Kuchipudi (12.22%)

Highest Public shareholder

Dheeraj Kumar Lohia (3.35%)

Individual Investors Holdings

45.91%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 23.49% vs 1.81% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 122.92% vs -1,060.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.51",
          "val2": "10.13",
          "chgp": "23.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.08",
          "val2": "1.02",
          "chgp": "103.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.43",
          "val2": "0.15",
          "chgp": "186.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.11",
          "val2": "-0.48",
          "chgp": "122.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.63%",
          "val2": "10.07%",
          "chgp": "6.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 31.60% vs 0.82% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 1,577.78% vs 88.89% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.28",
          "val2": "18.45",
          "chgp": "31.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.72",
          "val2": "2.63",
          "chgp": "117.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.78",
          "val2": "0.49",
          "chgp": "59.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.33",
          "val2": "-0.09",
          "chgp": "1,577.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.56%",
          "val2": "14.25%",
          "chgp": "9.31%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 28.73% vs 1.17% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 352.63% vs 25.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.79",
          "val2": "28.58",
          "chgp": "28.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.80",
          "val2": "3.65",
          "chgp": "113.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.21",
          "val2": "0.64",
          "chgp": "89.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.44",
          "val2": "-0.57",
          "chgp": "352.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.20%",
          "val2": "12.77%",
          "chgp": "8.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 9.59% vs -46.63% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 57.52% vs -125.63% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.65",
          "val2": "36.18",
          "chgp": "9.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.62",
          "val2": "1.29",
          "chgp": "258.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.97",
          "val2": "0.97",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.30",
          "val2": "-3.06",
          "chgp": "57.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.65%",
          "val2": "3.57%",
          "chgp": "8.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
12.51
10.13
23.49%
Operating Profit (PBDIT) excl Other Income
2.08
1.02
103.92%
Interest
0.43
0.15
186.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.11
-0.48
122.92%
Operating Profit Margin (Excl OI)
16.63%
10.07%
6.56%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 23.49% vs 1.81% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 122.92% vs -1,060.00% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
24.28
18.45
31.60%
Operating Profit (PBDIT) excl Other Income
5.72
2.63
117.49%
Interest
0.78
0.49
59.18%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.33
-0.09
1,577.78%
Operating Profit Margin (Excl OI)
23.56%
14.25%
9.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 31.60% vs 0.82% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 1,577.78% vs 88.89% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
36.79
28.58
28.73%
Operating Profit (PBDIT) excl Other Income
7.80
3.65
113.70%
Interest
1.21
0.64
89.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.44
-0.57
352.63%
Operating Profit Margin (Excl OI)
21.20%
12.77%
8.43%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 28.73% vs 1.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 352.63% vs 25.00% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
39.65
36.18
9.59%
Operating Profit (PBDIT) excl Other Income
4.62
1.29
258.14%
Interest
0.97
0.97
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.30
-3.06
57.52%
Operating Profit Margin (Excl OI)
11.65%
3.57%
8.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 9.59% vs -46.63% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 57.52% vs -125.63% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Jeevan Scientific Technology Ltd stock-summary
stock-summary
Jeevan Scientific Technology Ltd
Micro Cap
Pharmaceuticals & Drugs
Jeevan Scientific Technology Ltd (Erstwhile Jeevan Softech Limited) was incorporated on 2nd February, 1999 to carry on the business Clinical research, Data Management Services. The Company was promoted by Krishna Kishore Kuchipudi and K Vanaja. The Company is an Independent Clinical Contract Research Organization offering reliable, cost effective and technology-driven clinical research solutions to various clients across the globe.
Company Coordinates stock-summary
Company Details
Plot 1 & 2 Sai Krupa Enclave, Manikonda Jagir Nr Lanco Hills Hyderabad Telangana : 500008
stock-summary
Tel: 91-40-67364700
stock-summary
http://www.jeevanscientific.com
stock-summary
info@jeevanscientific.com
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."